Home » Newsletters » BioWorld Asia

BioWorld Asia

Jan. 31, 2001

View Archived Issues

Scotia Moves Into Administration Following Rejection Of Foscan

Mouse Embryo Development Hinges On Sperm Entry Point

ExonHit Sets Up Shop In U.S., Expands Into Heart Diseases

Eurogene Acquires Quattrogene, Phase II Product In Stock Deal

UK Approves Human Embryo Cloning; Ethics Debate Coming

French Researchers Show Value Of Stem Cells In Hair Follicles

New UK BIA Chairman Pushes Industry To Go On Offensive

Draft Report Sparks Debate Among European Ministers

German Government Commits DM1.5B To Biotech Research

Other News To Note

IDgene Raises $7.6M Privately For Genetic Variability Program

PPL Gets £42M Commitment For AAT Manufacturing Facility

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...